ORAGENICS, INC. Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
ORAGENICS, INC. (OGEN) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $46.23 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2026-03-16
- ORAGENICS, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2024 was $46.23K, a 93.20% decline from fiscal 2023.
- ORAGENICS, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2023 was $680.04K, a 489.31% increase from fiscal 2022.
- ORAGENICS, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2022 was $115.40K, a 78.01% decline from fiscal 2021.
- ORAGENICS, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2021 was $524.85K.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month |
|---|---|
| 2024-12-31 | $46.23K 10-K · filed 2026-03-16 |
| 2023-12-31 | $680.04K 10-K · filed 2025-03-14 |
| 2022-12-31 | $115.40K 10-K · filed 2025-03-14 |
| 2021-12-31 | $524.85K 10-K/A · filed 2022-07-29 |
| 2018-12-31 | $0.00 10-K · filed 2019-03-29 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-29 |
| 2016-12-31 | $0.00 10-K · filed 2018-02-16 |
| 2015-12-31 | $0.00 10-K · filed 2017-02-27 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-30 |
| 2013-12-31 | $0.00 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |